LT2205552T - Selektyvių androgeno moduliatorių (r) arba (s)-n-(4-ciano-3-(trifluormetil)fenil)-3-(4-cianofenoksi)-2-hidroksi-2-metilpropan-amido kristaliniai polimorfai - Google Patents

Selektyvių androgeno moduliatorių (r) arba (s)-n-(4-ciano-3-(trifluormetil)fenil)-3-(4-cianofenoksi)-2-hidroksi-2-metilpropan-amido kristaliniai polimorfai

Info

Publication number
LT2205552T
LT2205552T LTEP08799476.0T LT08799476T LT2205552T LT 2205552 T LT2205552 T LT 2205552T LT 08799476 T LT08799476 T LT 08799476T LT 2205552 T LT2205552 T LT 2205552T
Authority
LT
Lithuania
Prior art keywords
methylpropanamide
cyanophenoxy
trifluoromethyl
cyano
hydroxy
Prior art date
Application number
LTEP08799476.0T
Other languages
English (en)
Lithuanian (lt)
Inventor
Tai Ahn
James Dalton
Dave Dickason
David Hong
Thomas Bird
Original Assignee
Gtx, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gtx, Inc. filed Critical Gtx, Inc.
Publication of LT2205552T publication Critical patent/LT2205552T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00Preparation of carboxylic acid nitriles
    • C07C253/30Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/60Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton at least one of the singly-bound nitrogen atoms being acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEP08799476.0T 2007-09-11 2008-09-11 Selektyvių androgeno moduliatorių (r) arba (s)-n-(4-ciano-3-(trifluormetil)fenil)-3-(4-cianofenoksi)-2-hidroksi-2-metilpropan-amido kristaliniai polimorfai LT2205552T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96001207P 2007-09-11 2007-09-11
PCT/US2008/076066 WO2009036206A1 (en) 2007-09-11 2008-09-11 Solid forms of selective androgen receptor modulators

Publications (1)

Publication Number Publication Date
LT2205552T true LT2205552T (lt) 2018-04-10

Family

ID=40452483

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP08799476.0T LT2205552T (lt) 2007-09-11 2008-09-11 Selektyvių androgeno moduliatorių (r) arba (s)-n-(4-ciano-3-(trifluormetil)fenil)-3-(4-cianofenoksi)-2-hidroksi-2-metilpropan-amido kristaliniai polimorfai

Country Status (20)

Country Link
US (1) US7977386B2 (el)
EP (2) EP2205552B1 (el)
JP (3) JP5452492B2 (el)
KR (3) KR101580905B1 (el)
CN (3) CN101855198B (el)
AU (1) AU2008298901C1 (el)
CA (3) CA2886498C (el)
CY (1) CY1120107T1 (el)
DK (1) DK2205552T3 (el)
EA (1) EA018611B1 (el)
ES (1) ES2665007T3 (el)
HR (1) HRP20180500T1 (el)
HU (1) HUE036762T2 (el)
IL (2) IL204352A (el)
LT (1) LT2205552T (el)
MX (6) MX360801B (el)
NO (1) NO2205552T3 (el)
PL (1) PL2205552T3 (el)
PT (1) PT2205552T (el)
WO (1) WO2009036206A1 (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7855229B2 (en) * 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
US7919647B2 (en) 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
US8853266B2 (en) * 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US20110237664A1 (en) * 2004-06-07 2011-09-29 Dalton James T Selective androgen receptor modulators for treating diabetes
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
CA2886498C (en) * 2007-09-11 2017-09-26 Gtx, Inc. Solid forms of selective androgen receptor modulators
RU2012134351A (ru) * 2010-01-11 2014-02-20 ДЖиТиЭкс, ИНК. Способы лечения дисфункции мейбомиевых желез
US10314807B2 (en) 2012-07-13 2019-06-11 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US10987334B2 (en) 2012-07-13 2021-04-27 University Of Tennessee Research Foundation Method of treating ER mutant expressing breast cancers with selective androgen receptor modulators (SARMs)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US9969683B2 (en) 2012-07-13 2018-05-15 Gtx, Inc. Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS)
KR102122941B1 (ko) 2012-07-13 2020-06-15 지티엑스, 인코포레이티드 선택적 안드로겐 수용체 조절자(sarms)를 이용한 안드로겐 수용체(ar) 양성 유방암의 치료 방법
TWI726969B (zh) 2016-01-11 2021-05-11 比利時商健生藥品公司 用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
CN110563607B (zh) * 2019-10-25 2022-07-08 许昌远志生物科技有限公司 一种mk-2866的精制方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050038110A1 (en) 2000-08-24 2005-02-17 Steiner Mitchell S. Selective androgen receptor modulators and methods of use thereof
US20070173546A1 (en) 2000-08-24 2007-07-26 Dalton James T Selective androgen receptor modulators and method of use thereof
ATE423092T1 (de) * 2000-08-24 2009-03-15 Univ Tennessee Res Foundation Selektive modulatoren des androgenrezeptors und methoden zu deren verwendung
US7919647B2 (en) 2000-08-24 2011-04-05 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7026500B2 (en) * 2000-08-24 2006-04-11 University Of Tennessee Research Foundation Halogenated selective androgen receptor modulators and methods of use thereof
US7622503B2 (en) 2000-08-24 2009-11-24 University Of Tennessee Research Foundation Selective androgen receptor modulators and methods of use thereof
US7645898B2 (en) * 2000-08-24 2010-01-12 University Of Tennessee Research Foundation Selective androgen receptor modulators and method of use thereof
US7855229B2 (en) 2000-08-24 2010-12-21 University Of Tennessee Research Foundation Treating wasting disorders with selective androgen receptor modulators
EP1322603A1 (en) * 2000-09-21 2003-07-02 Bristol-Myers Squibb Company Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl- and heteroarylsulfonyl-2-hydroxy-2-alkyl- and haloalkylpropanamide compounds
US20070161608A1 (en) * 2001-12-06 2007-07-12 Dalton James T Selective androgen receptor modulators for treating muscle wasting
US8853266B2 (en) 2001-12-06 2014-10-07 University Of Tennessee Research Foundation Selective androgen receptor modulators for treating diabetes
JP4605557B2 (ja) * 2001-12-06 2011-01-05 ユニバーシティ オブ テネシー リサーチ ファウンデーション 選択的アンドロゲンレセプタ修飾因子を用いた筋萎縮治療
KR20040101251A (ko) * 2002-02-28 2004-12-02 유니버시티 오브 테네시 리서치 파운데이션 다치환된 선택적 안드로겐 수용체 모듈레이터 및 이를사용하는 방법
JP2006506369A (ja) * 2002-10-15 2006-02-23 ユニバーシティ・オブ・テネシー・リサーチ・ファウンデーション メチレン架橋選択的アンドロゲン受容体調節剤及びその使用方法
EP2457892A1 (en) * 2003-01-13 2012-05-30 University of Tennessee Research Foundation Large-scale synthesis of selective androgen receptor modulators
EP2476415A3 (en) 2003-10-14 2012-08-29 University of Tennessee Research Foundation Treating bone-related disorders with selective androgen receptor modulators
EP2425715B1 (en) 2005-08-31 2014-03-05 University of Tennessee Research Foundation Treating symptoms of renal disease with selective androgen receptor modulators (SARM)
TW200730505A (en) * 2005-12-07 2007-08-16 Merck & Co Inc Polymorphs of an androgen receptor modulator
CN1825959A (zh) * 2006-03-02 2006-08-30 复旦大学 一种基于自适应多步搜索的图像跟踪算法
CA2886498C (en) * 2007-09-11 2017-09-26 Gtx, Inc. Solid forms of selective androgen receptor modulators
US7968603B2 (en) * 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators

Also Published As

Publication number Publication date
EP2205552A4 (en) 2012-04-18
JP5599380B2 (ja) 2014-10-01
CN101855198B (zh) 2013-07-10
CN103553966A (zh) 2014-02-05
ES2665007T3 (es) 2018-04-24
CN103073450A (zh) 2013-05-01
WO2009036206A1 (en) 2009-03-19
PT2205552T (pt) 2018-04-24
CN103073450B (zh) 2014-12-03
MX336760B (es) 2016-01-29
CA2709118C (en) 2018-03-13
HUE036762T2 (hu) 2018-07-30
PL2205552T3 (pl) 2018-07-31
CA2886501C (en) 2018-03-27
CA2886501A1 (en) 2009-03-19
MX351941B (es) 2017-11-03
AU2008298901C1 (en) 2013-10-03
EP2205552A1 (en) 2010-07-14
KR101580905B1 (ko) 2015-12-29
CN103553966B (zh) 2016-09-07
NO2205552T3 (el) 2018-07-28
KR101691877B1 (ko) 2017-01-02
EP2205552B1 (en) 2018-02-28
EA018611B1 (ru) 2013-09-30
IL204352A (en) 2013-10-31
JP5452492B2 (ja) 2014-03-26
MX360801B (es) 2018-11-16
JP5727636B2 (ja) 2015-06-03
US20090088480A1 (en) 2009-04-02
CA2886498C (en) 2017-09-26
JP2012067118A (ja) 2012-04-05
KR20100090239A (ko) 2010-08-13
EA201070350A1 (ru) 2010-12-30
AU2008298901B2 (en) 2013-05-09
CA2886498A1 (en) 2009-03-19
DK2205552T3 (en) 2018-04-16
KR20170001736A (ko) 2017-01-04
IL251483A0 (en) 2017-05-29
CN101855198A (zh) 2010-10-06
MX341090B (es) 2016-08-08
EP2871177B1 (en) 2019-07-17
AU2008298901A1 (en) 2009-03-19
HRP20180500T1 (hr) 2018-06-01
MX2010002784A (es) 2011-06-01
KR20160003335A (ko) 2016-01-08
CY1120107T1 (el) 2018-12-12
JP2014133744A (ja) 2014-07-24
JP2010539181A (ja) 2010-12-16
CA2709118A1 (en) 2009-03-19
US7977386B2 (en) 2011-07-12
EP2871177A1 (en) 2015-05-13
MX2018014065A (es) 2020-09-02

Similar Documents

Publication Publication Date Title
HRP20180500T1 (hr) Kristalni polimorf selektivnih modulatora androgena (r) ili (s)-n-(4-cijano-3-(trifluorometil)fenil)-3-(4-cijanofenoksi)-2-hidroksi-2-metilpropanamida
IL242538A (en) Composition containing (s) –n– (3– chloro – 4 – cyanophenyl) –3– (4 – cyanophenoxy) -2
PL1846566T3 (pl) Stabilne kryształy natamycyny o kształcie igiełkowatym
IL244442A0 (en) Compounds of converted acylanilides and their use
SI2097381T1 (sl) 4-(4-((4-kloro-3-(trifluorometil)fenil))karbamoil)amino)-3- fluorofenoksi)-n-metilpiridin-2-karbokasamid monohidrat
HK1083341A1 (en) Stable crystal of 4-oxoquinoline compound
EP1953151A4 (en) SALTS FROM A CYNNAMIDE COMPOUND OR SOLVATE THEREOF
GB0714030D0 (en) The use of type-B lantibiotic-based compounds having antimicrobial activity
ZA200808182B (en) Herbicidal mixture comprising diuron and mesotrione
ZA200906737B (en) Novel benzamide derivatives as modulators of the follicle stimulating hormone
IL196432A0 (en) Nanoparticulate formulations of modafinil
IL191052A0 (en) Process for the preparation of tamsulosin and related compounds
HK1223606A1 (zh) 三氟甲基 苯甲基 -甲氧基丁醯胺的多晶型物
ZA200805701B (en) Salts of styphnic acid
EP1889841A4 (en) CRYSTAL OF A SALT OF A BENZIMIDAZOLE COMPOUND
GB0604772D0 (en) Use of substituted amine compounds for the treatment of food related disorders
ITMI20061606A1 (it) Procedimento per la preparazione di composti nitrilici
PT2374897E (pt) Cristais estáveis de natamicina em forma de agulha
GB0419565D0 (en) Benzamide compounds
ZA200900186B (en) Nanoparticulate formulations of modafinil
PL116389U1 (en) Head of cheese
GB0502545D0 (en) Benzamide compounds